nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ABCB1—colon cancer	0.337	1	CbGaD
Vismodegib—ABCG2—Irinotecan—colon cancer	0.0629	0.128	CbGbCtD
Vismodegib—ABCG2—Fluorouracil—colon cancer	0.0604	0.123	CbGbCtD
Vismodegib—ABCG2—Vincristine—colon cancer	0.055	0.112	CbGbCtD
Vismodegib—ALB—Irinotecan—colon cancer	0.0434	0.0882	CbGbCtD
Vismodegib—ALB—Fluorouracil—colon cancer	0.0416	0.0846	CbGbCtD
Vismodegib—CYP2C9—Capecitabine—colon cancer	0.0378	0.0769	CbGbCtD
Vismodegib—ABCG2—Methotrexate—colon cancer	0.0333	0.0677	CbGbCtD
Vismodegib—CYP2C8—Fluorouracil—colon cancer	0.0322	0.0654	CbGbCtD
Vismodegib—ALB—Methotrexate—colon cancer	0.0229	0.0467	CbGbCtD
Vismodegib—ABCB1—Irinotecan—colon cancer	0.0227	0.0461	CbGbCtD
Vismodegib—CYP2C9—Fluorouracil—colon cancer	0.0224	0.0456	CbGbCtD
Vismodegib—ABCB1—Vincristine—colon cancer	0.0198	0.0403	CbGbCtD
Vismodegib—CYP3A4—Irinotecan—colon cancer	0.0136	0.0276	CbGbCtD
Vismodegib—ABCB1—Methotrexate—colon cancer	0.012	0.0244	CbGbCtD
Vismodegib—CYP3A4—Vincristine—colon cancer	0.0119	0.0241	CbGbCtD
Vismodegib—ORM1—bile—colon cancer	0.00919	0.16	CbGeAlD
Vismodegib—Sodium decreased—Capecitabine—colon cancer	0.00537	0.0888	CcSEcCtD
Vismodegib—SHH—embryo—colon cancer	0.00529	0.0923	CbGeAlD
Vismodegib—SHH—epithelium—colon cancer	0.00432	0.0753	CbGeAlD
Vismodegib—SHH—renal system—colon cancer	0.004	0.0699	CbGeAlD
Vismodegib—SMO—embryo—colon cancer	0.0037	0.0646	CbGeAlD
Vismodegib—Potassium low—Capecitabine—colon cancer	0.00347	0.0574	CcSEcCtD
Vismodegib—SHH—digestive system—colon cancer	0.00328	0.0573	CbGeAlD
Vismodegib—SHH—bone marrow—colon cancer	0.00303	0.0528	CbGeAlD
Vismodegib—ORM1—gall bladder—colon cancer	0.00255	0.0445	CbGeAlD
Vismodegib—ALB—gall bladder—colon cancer	0.00224	0.039	CbGeAlD
Vismodegib—Sorafenib—BRAF—colon cancer	0.00215	0.358	CrCbGaD
Vismodegib—Azotaemia—Vincristine—colon cancer	0.00209	0.0346	CcSEcCtD
Vismodegib—SMO—vagina—colon cancer	0.00203	0.0354	CbGeAlD
Vismodegib—Blood potassium decreased—Capecitabine—colon cancer	0.00191	0.0316	CcSEcCtD
Vismodegib—SMO—liver—colon cancer	0.00171	0.0299	CbGeAlD
Vismodegib—SMO—lymph node—colon cancer	0.00131	0.0229	CbGeAlD
Vismodegib—Neoplasm malignant—Irinotecan—colon cancer	0.00127	0.021	CcSEcCtD
Vismodegib—Sulfasalazine—PPARG—colon cancer	0.00117	0.196	CrCbGaD
Vismodegib—Musculoskeletal pain—Vincristine—colon cancer	0.00113	0.0187	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Irinotecan—colon cancer	0.00109	0.018	CcSEcCtD
Vismodegib—Azotaemia—Methotrexate—colon cancer	0.00101	0.0168	CcSEcCtD
Vismodegib—Tolvaptan—ABCB1—colon cancer	0.000944	0.157	CrCbGaD
Vismodegib—ORM1—bone marrow—colon cancer	0.000925	0.0161	CbGeAlD
Vismodegib—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.000905	0.015	CcSEcCtD
Vismodegib—Ageusia—Capecitabine—colon cancer	0.000896	0.0148	CcSEcCtD
Vismodegib—Etoricoxib—PTGS2—colon cancer	0.000841	0.14	CrCbGaD
Vismodegib—Hyponatraemia—Vincristine—colon cancer	0.000812	0.0134	CcSEcCtD
Vismodegib—Pain in extremity—Vincristine—colon cancer	0.000809	0.0134	CcSEcCtD
Vismodegib—ABCB1—blood vessel—colon cancer	0.000801	0.014	CbGeAlD
Vismodegib—Hyponatraemia—Irinotecan—colon cancer	0.000791	0.0131	CcSEcCtD
Vismodegib—CYP2C8—renal system—colon cancer	0.000754	0.0132	CbGeAlD
Vismodegib—Dehydration—Vincristine—colon cancer	0.000752	0.0125	CcSEcCtD
Vismodegib—ORM1—liver—colon cancer	0.000748	0.013	CbGeAlD
Vismodegib—Dehydration—Irinotecan—colon cancer	0.000732	0.0121	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Vincristine—colon cancer	0.000728	0.0121	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Capecitabine—colon cancer	0.000726	0.012	CcSEcCtD
Vismodegib—Hypokalaemia—Irinotecan—colon cancer	0.000717	0.0119	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.000709	0.0117	CcSEcCtD
Vismodegib—CYP2C19—digestive system—colon cancer	0.000709	0.0124	CbGeAlD
Vismodegib—ALB—liver—colon cancer	0.000656	0.0114	CbGeAlD
Vismodegib—Weight decreased—Vincristine—colon cancer	0.000632	0.0105	CcSEcCtD
Vismodegib—CYP2C19—vagina—colon cancer	0.000626	0.0109	CbGeAlD
Vismodegib—Weight decreased—Irinotecan—colon cancer	0.000616	0.0102	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.000606	0.01	CcSEcCtD
Vismodegib—ORM1—lymph node—colon cancer	0.000573	0.01	CbGeAlD
Vismodegib—Hepatic enzyme increased—Methotrexate—colon cancer	0.000572	0.00946	CcSEcCtD
Vismodegib—ABCG2—bone marrow—colon cancer	0.000554	0.00967	CbGeAlD
Vismodegib—Connective tissue disorder—Vincristine—colon cancer	0.00055	0.0091	CcSEcCtD
Vismodegib—CYP2C9—digestive system—colon cancer	0.000549	0.00959	CbGeAlD
Vismodegib—CYP2C8—vagina—colon cancer	0.000546	0.00953	CbGeAlD
Vismodegib—Connective tissue disorder—Irinotecan—colon cancer	0.000535	0.00886	CcSEcCtD
Vismodegib—ABCG2—vagina—colon cancer	0.000531	0.00927	CbGeAlD
Vismodegib—Hyponatraemia—Capecitabine—colon cancer	0.000529	0.00876	CcSEcCtD
Vismodegib—CYP2C19—liver—colon cancer	0.000528	0.00921	CbGeAlD
Vismodegib—Pain in extremity—Capecitabine—colon cancer	0.000527	0.00873	CcSEcCtD
Vismodegib—CYP3A4—renal system—colon cancer	0.000511	0.00891	CbGeAlD
Vismodegib—ALB—lymph node—colon cancer	0.000503	0.00877	CbGeAlD
Vismodegib—Sulfasalazine—PTGS2—colon cancer	0.000496	0.0826	CrCbGaD
Vismodegib—Alopecia—Vincristine—colon cancer	0.000494	0.00818	CcSEcCtD
Vismodegib—Dehydration—Capecitabine—colon cancer	0.00049	0.00812	CcSEcCtD
Vismodegib—Alopecia—Irinotecan—colon cancer	0.000481	0.00797	CcSEcCtD
Vismodegib—Abdominal pain upper—Capecitabine—colon cancer	0.000481	0.00797	CcSEcCtD
Vismodegib—Hypokalaemia—Capecitabine—colon cancer	0.00048	0.00794	CcSEcCtD
Vismodegib—ABCB1—embryo—colon cancer	0.000478	0.00834	CbGeAlD
Vismodegib—Breast disorder—Capecitabine—colon cancer	0.000476	0.00789	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000475	0.00786	CcSEcCtD
Vismodegib—Back pain—Vincristine—colon cancer	0.000471	0.0078	CcSEcCtD
Vismodegib—Alopecia—Fluorouracil—colon cancer	0.000461	0.00763	CcSEcCtD
Vismodegib—CYP2C8—liver—colon cancer	0.000461	0.00804	CbGeAlD
Vismodegib—Back pain—Irinotecan—colon cancer	0.000459	0.0076	CcSEcCtD
Vismodegib—Muscle spasms—Irinotecan—colon cancer	0.000456	0.00755	CcSEcCtD
Vismodegib—ABCG2—liver—colon cancer	0.000448	0.00782	CbGeAlD
Vismodegib—CYP3A4—digestive system—colon cancer	0.000419	0.00731	CbGeAlD
Vismodegib—Myalgia—Vincristine—colon cancer	0.000415	0.00686	CcSEcCtD
Vismodegib—Weight decreased—Capecitabine—colon cancer	0.000412	0.00682	CcSEcCtD
Vismodegib—CYP2C9—liver—colon cancer	0.000409	0.00714	CbGeAlD
Vismodegib—Sorafenib—ABCB1—colon cancer	0.000398	0.0663	CrCbGaD
Vismodegib—ABCB1—epithelium—colon cancer	0.00039	0.0068	CbGeAlD
Vismodegib—Nervous system disorder—Vincristine—colon cancer	0.00039	0.00645	CcSEcCtD
Vismodegib—Myalgia—Fluorouracil—colon cancer	0.000387	0.0064	CcSEcCtD
Vismodegib—Nervous system disorder—Irinotecan—colon cancer	0.00038	0.00628	CcSEcCtD
Vismodegib—Nervous system disorder—Fluorouracil—colon cancer	0.000364	0.00602	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Vincristine—colon cancer	0.000362	0.006	CcSEcCtD
Vismodegib—ABCB1—renal system—colon cancer	0.000362	0.00631	CbGeAlD
Vismodegib—Connective tissue disorder—Capecitabine—colon cancer	0.000358	0.00593	CcSEcCtD
Vismodegib—Breast disorder—Methotrexate—colon cancer	0.000355	0.00587	CcSEcCtD
Vismodegib—Decreased appetite—Vincristine—colon cancer	0.000346	0.00572	CcSEcCtD
Vismodegib—ABCG2—lymph node—colon cancer	0.000344	0.00599	CbGeAlD
Vismodegib—Gastrointestinal disorder—Vincristine—colon cancer	0.000343	0.00568	CcSEcCtD
Vismodegib—Fatigue—Vincristine—colon cancer	0.000343	0.00567	CcSEcCtD
Vismodegib—Dyspepsia—Irinotecan—colon cancer	0.000341	0.00564	CcSEcCtD
Vismodegib—Pain—Vincristine—colon cancer	0.00034	0.00563	CcSEcCtD
Vismodegib—Constipation—Vincristine—colon cancer	0.00034	0.00563	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000338	0.00559	CcSEcCtD
Vismodegib—Decreased appetite—Irinotecan—colon cancer	0.000336	0.00557	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Irinotecan—colon cancer	0.000334	0.00553	CcSEcCtD
Vismodegib—Fatigue—Irinotecan—colon cancer	0.000334	0.00553	CcSEcCtD
Vismodegib—Pain—Irinotecan—colon cancer	0.000331	0.00548	CcSEcCtD
Vismodegib—Constipation—Irinotecan—colon cancer	0.000331	0.00548	CcSEcCtD
Vismodegib—Dyspepsia—Fluorouracil—colon cancer	0.000326	0.0054	CcSEcCtD
Vismodegib—Gastrointestinal pain—Vincristine—colon cancer	0.000325	0.00538	CcSEcCtD
Vismodegib—Decreased appetite—Fluorouracil—colon cancer	0.000322	0.00534	CcSEcCtD
Vismodegib—Alopecia—Capecitabine—colon cancer	0.000322	0.00533	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00032	0.0053	CcSEcCtD
Vismodegib—Malnutrition—Capecitabine—colon cancer	0.000317	0.00526	CcSEcCtD
Vismodegib—Pain—Fluorouracil—colon cancer	0.000317	0.00525	CcSEcCtD
Vismodegib—Gastrointestinal pain—Irinotecan—colon cancer	0.000317	0.00524	CcSEcCtD
Vismodegib—Abdominal pain—Vincristine—colon cancer	0.000314	0.0052	CcSEcCtD
Vismodegib—CYP3A4—liver—colon cancer	0.000312	0.00545	CbGeAlD
Vismodegib—Dysgeusia—Capecitabine—colon cancer	0.000311	0.00515	CcSEcCtD
Vismodegib—Back pain—Capecitabine—colon cancer	0.000307	0.00508	CcSEcCtD
Vismodegib—Abdominal pain—Irinotecan—colon cancer	0.000306	0.00507	CcSEcCtD
Vismodegib—Muscle spasms—Capecitabine—colon cancer	0.000305	0.00505	CcSEcCtD
Vismodegib—ABCB1—lymphoid tissue—colon cancer	0.0003	0.00524	CbGeAlD
Vismodegib—ABCB1—digestive system—colon cancer	0.000297	0.00517	CbGeAlD
Vismodegib—Asthenia—Vincristine—colon cancer	0.000285	0.00472	CcSEcCtD
Vismodegib—Asthenia—Irinotecan—colon cancer	0.000278	0.0046	CcSEcCtD
Vismodegib—ABCB1—bone marrow—colon cancer	0.000273	0.00477	CbGeAlD
Vismodegib—Diarrhoea—Vincristine—colon cancer	0.000272	0.0045	CcSEcCtD
Vismodegib—Arthralgia—Capecitabine—colon cancer	0.00027	0.00447	CcSEcCtD
Vismodegib—Myalgia—Capecitabine—colon cancer	0.00027	0.00447	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000268	0.00444	CcSEcCtD
Vismodegib—Diarrhoea—Irinotecan—colon cancer	0.000265	0.00438	CcSEcCtD
Vismodegib—Pruritus—Fluorouracil—colon cancer	0.000262	0.00434	CcSEcCtD
Vismodegib—ABCB1—vagina—colon cancer	0.000262	0.00457	CbGeAlD
Vismodegib—Nervous system disorder—Capecitabine—colon cancer	0.000254	0.00421	CcSEcCtD
Vismodegib—Diarrhoea—Fluorouracil—colon cancer	0.000254	0.0042	CcSEcCtD
Vismodegib—Vomiting—Vincristine—colon cancer	0.000253	0.00418	CcSEcCtD
Vismodegib—Skin disorder—Capecitabine—colon cancer	0.000252	0.00417	CcSEcCtD
Vismodegib—Rash—Vincristine—colon cancer	0.000251	0.00415	CcSEcCtD
Vismodegib—Dermatitis—Vincristine—colon cancer	0.00025	0.00415	CcSEcCtD
Vismodegib—Vomiting—Irinotecan—colon cancer	0.000246	0.00407	CcSEcCtD
Vismodegib—Rash—Irinotecan—colon cancer	0.000244	0.00404	CcSEcCtD
Vismodegib—Dermatitis—Irinotecan—colon cancer	0.000244	0.00404	CcSEcCtD
Vismodegib—Alopecia—Methotrexate—colon cancer	0.00024	0.00397	CcSEcCtD
Vismodegib—Malnutrition—Methotrexate—colon cancer	0.000236	0.00391	CcSEcCtD
Vismodegib—Nausea—Vincristine—colon cancer	0.000236	0.00391	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000236	0.00391	CcSEcCtD
Vismodegib—Vomiting—Fluorouracil—colon cancer	0.000236	0.0039	CcSEcCtD
Vismodegib—Rash—Fluorouracil—colon cancer	0.000234	0.00387	CcSEcCtD
Vismodegib—Dermatitis—Fluorouracil—colon cancer	0.000234	0.00387	CcSEcCtD
Vismodegib—Dysgeusia—Methotrexate—colon cancer	0.000231	0.00383	CcSEcCtD
Vismodegib—Nausea—Irinotecan—colon cancer	0.00023	0.00381	CcSEcCtD
Vismodegib—Back pain—Methotrexate—colon cancer	0.000229	0.00378	CcSEcCtD
Vismodegib—Dyspepsia—Capecitabine—colon cancer	0.000228	0.00378	CcSEcCtD
Vismodegib—Decreased appetite—Capecitabine—colon cancer	0.000225	0.00373	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Capecitabine—colon cancer	0.000224	0.0037	CcSEcCtD
Vismodegib—Fatigue—Capecitabine—colon cancer	0.000223	0.0037	CcSEcCtD
Vismodegib—Constipation—Capecitabine—colon cancer	0.000222	0.00367	CcSEcCtD
Vismodegib—Pain—Capecitabine—colon cancer	0.000222	0.00367	CcSEcCtD
Vismodegib—ABCB1—liver—colon cancer	0.000221	0.00386	CbGeAlD
Vismodegib—Nausea—Fluorouracil—colon cancer	0.00022	0.00365	CcSEcCtD
Vismodegib—Gastrointestinal pain—Capecitabine—colon cancer	0.000212	0.00351	CcSEcCtD
Vismodegib—Abdominal pain—Capecitabine—colon cancer	0.000205	0.00339	CcSEcCtD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000204	0.00433	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000204	0.00432	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000202	0.00429	CbGpPWpGaD
Vismodegib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000202	0.00429	CbGpPWpGaD
Vismodegib—Arthralgia—Methotrexate—colon cancer	0.000201	0.00333	CcSEcCtD
Vismodegib—Myalgia—Methotrexate—colon cancer	0.000201	0.00333	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.0002	0.00331	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000198	0.00421	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000196	0.00417	CbGpPWpGaD
Vismodegib—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000195	0.00415	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000192	0.00408	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000192	0.00407	CbGpPWpGaD
Vismodegib—Nervous system disorder—Methotrexate—colon cancer	0.000189	0.00313	CcSEcCtD
Vismodegib—Skin disorder—Methotrexate—colon cancer	0.000187	0.0031	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000187	0.00397	CbGpPWpGaD
Vismodegib—Asthenia—Capecitabine—colon cancer	0.000186	0.00308	CcSEcCtD
Vismodegib—Pruritus—Capecitabine—colon cancer	0.000183	0.00303	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000182	0.00387	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000182	0.00387	CbGpPWpGaD
Vismodegib—ABCG2—HIF-2-alpha transcription factor network—EP300—colon cancer	0.000182	0.00387	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AXIN2—colon cancer	0.000179	0.00379	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000177	0.00377	CbGpPWpGaD
Vismodegib—Diarrhoea—Capecitabine—colon cancer	0.000177	0.00293	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000176	0.00291	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000173	0.00367	CbGpPWpGaD
Vismodegib—ABCG2—HIF-2-alpha transcription factor network—VEGFA—colon cancer	0.000172	0.00366	CbGpPWpGaD
Vismodegib—Dyspepsia—Methotrexate—colon cancer	0.00017	0.00281	CcSEcCtD
Vismodegib—ABCB1—lymph node—colon cancer	0.000169	0.00296	CbGeAlD
Vismodegib—SMO—Signaling Pathways—AXIN2—colon cancer	0.000169	0.0036	CbGpPWpGaD
Vismodegib—Decreased appetite—Methotrexate—colon cancer	0.000168	0.00278	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000168	0.00356	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000167	0.00355	CbGpPWpGaD
Vismodegib—Gastrointestinal disorder—Methotrexate—colon cancer	0.000167	0.00276	CcSEcCtD
Vismodegib—Fatigue—Methotrexate—colon cancer	0.000166	0.00275	CcSEcCtD
Vismodegib—Pain—Methotrexate—colon cancer	0.000165	0.00273	CcSEcCtD
Vismodegib—Vomiting—Capecitabine—colon cancer	0.000165	0.00273	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000164	0.00348	CbGpPWpGaD
Vismodegib—Rash—Capecitabine—colon cancer	0.000163	0.0027	CcSEcCtD
Vismodegib—Dermatitis—Capecitabine—colon cancer	0.000163	0.0027	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000159	0.00337	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000159	0.00337	CbGpPWpGaD
Vismodegib—Gastrointestinal pain—Methotrexate—colon cancer	0.000158	0.00261	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000155	0.0033	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000155	0.00329	CbGpPWpGaD
Vismodegib—Nausea—Capecitabine—colon cancer	0.000154	0.00255	CcSEcCtD
Vismodegib—Abdominal pain—Methotrexate—colon cancer	0.000152	0.00252	CcSEcCtD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000152	0.00322	CbGpPWpGaD
Vismodegib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00015	0.0032	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000147	0.00312	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000142	0.00302	CbGpPWpGaD
Vismodegib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000141	0.00299	CbGpPWpGaD
Vismodegib—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00014	0.00297	CbGpPWpGaD
Vismodegib—Asthenia—Methotrexate—colon cancer	0.000138	0.00229	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000138	0.00292	CbGpPWpGaD
Vismodegib—Pruritus—Methotrexate—colon cancer	0.000136	0.00226	CcSEcCtD
Vismodegib—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000136	0.00289	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000135	0.00286	CbGpPWpGaD
Vismodegib—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	0.000133	0.00283	CbGpPWpGaD
Vismodegib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000133	0.00283	CbGpPWpGaD
Vismodegib—Diarrhoea—Methotrexate—colon cancer	0.000132	0.00218	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.00013	0.00277	CbGpPWpGaD
Vismodegib—Vomiting—Methotrexate—colon cancer	0.000123	0.00203	CcSEcCtD
Vismodegib—Rash—Methotrexate—colon cancer	0.000122	0.00201	CcSEcCtD
Vismodegib—Dermatitis—Methotrexate—colon cancer	0.000121	0.00201	CcSEcCtD
Vismodegib—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	0.000118	0.00252	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CA7—colon cancer	0.000117	0.00248	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000116	0.00247	CbGpPWpGaD
Vismodegib—Nausea—Methotrexate—colon cancer	0.000115	0.0019	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.00011	0.00234	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	0.000107	0.00227	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000104	0.0022	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.000101	0.00215	CbGpPWpGaD
Vismodegib—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	9.98e-05	0.00212	CbGpPWpGaD
Vismodegib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	9.27e-05	0.00197	CbGpPWpGaD
Vismodegib—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	8.91e-05	0.00189	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	8.71e-05	0.00185	CbGpPWpGaD
Vismodegib—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	8.12e-05	0.00173	CbGpPWpGaD
Vismodegib—SHH—Disease—FGFR3—colon cancer	7.37e-05	0.00156	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CA7—colon cancer	7.25e-05	0.00154	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CA7—colon cancer	7.21e-05	0.00153	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ODC1—colon cancer	7.08e-05	0.0015	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CHST5—colon cancer	7.08e-05	0.0015	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	6.96e-05	0.00148	CbGpPWpGaD
Vismodegib—SHH—Disease—APC—colon cancer	6.76e-05	0.00144	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	6.47e-05	0.00137	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CA7—colon cancer	6.47e-05	0.00137	CbGpPWpGaD
Vismodegib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	6.4e-05	0.00136	CbGpPWpGaD
Vismodegib—SHH—Disease—BRAF—colon cancer	6.36e-05	0.00135	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CA7—colon cancer	6.32e-05	0.00134	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	6.31e-05	0.00134	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CA7—colon cancer	5.9e-05	0.00125	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	5.79e-05	0.00123	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CASP3—colon cancer	5.6e-05	0.00119	CbGpPWpGaD
Vismodegib—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	5.52e-05	0.00117	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	5.48e-05	0.00116	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—VEGFA—colon cancer	5.37e-05	0.00114	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	5.34e-05	0.00113	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—FGFR3—colon cancer	5.16e-05	0.0011	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	5.14e-05	0.00109	CbGpPWpGaD
Vismodegib—SHH—Disease—PTGS2—colon cancer	5.14e-05	0.00109	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	5.11e-05	0.00109	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—TGFB1—colon cancer	4.93e-05	0.00105	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—FGFR3—colon cancer	4.89e-05	0.00104	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—VEGFA—colon cancer	4.75e-05	0.00101	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—APC—colon cancer	4.74e-05	0.00101	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—NRAS—colon cancer	4.74e-05	0.00101	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—colon cancer	4.73e-05	0.001	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	4.69e-05	0.000997	CbGpPWpGaD
Vismodegib—SHH—Disease—CTNNB1—colon cancer	4.6e-05	0.000976	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—APC—colon cancer	4.49e-05	0.000954	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—NRAS—colon cancer	4.49e-05	0.000954	CbGpPWpGaD
Vismodegib—SHH—Disease—CDKN1A—colon cancer	4.49e-05	0.000953	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—BRAF—colon cancer	4.45e-05	0.000946	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ODC1—colon cancer	4.39e-05	0.000933	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CHST5—colon cancer	4.39e-05	0.000933	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ODC1—colon cancer	4.37e-05	0.000927	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CHST5—colon cancer	4.37e-05	0.000927	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TGFB1—colon cancer	4.36e-05	0.000926	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—EGFR—colon cancer	4.32e-05	0.000916	CbGpPWpGaD
Vismodegib—SHH—Disease—EP300—colon cancer	4.27e-05	0.000907	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—BRAF—colon cancer	4.22e-05	0.000896	CbGpPWpGaD
Vismodegib—SHH—Disease—SRC—colon cancer	4.15e-05	0.000882	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—EGFR—colon cancer	4.09e-05	0.000869	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—KRAS—colon cancer	4.08e-05	0.000866	CbGpPWpGaD
Vismodegib—SHH—Disease—NRAS—colon cancer	4e-05	0.000849	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	3.99e-05	0.000848	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ODC1—colon cancer	3.92e-05	0.000833	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CHST5—colon cancer	3.92e-05	0.000833	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	3.92e-05	0.000832	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CA7—colon cancer	3.89e-05	0.000826	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—KRAS—colon cancer	3.86e-05	0.000821	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CHST5—colon cancer	3.83e-05	0.000813	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ODC1—colon cancer	3.83e-05	0.000813	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—PIK3CA—colon cancer	3.75e-05	0.000795	CbGpPWpGaD
Vismodegib—SHH—Disease—MYC—colon cancer	3.72e-05	0.00079	CbGpPWpGaD
Vismodegib—SHH—Disease—TGFB1—colon cancer	3.71e-05	0.000789	CbGpPWpGaD
Vismodegib—SHH—Disease—EGFR—colon cancer	3.64e-05	0.000773	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ODC1—colon cancer	3.57e-05	0.000759	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CHST5—colon cancer	3.57e-05	0.000759	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—PIK3CA—colon cancer	3.55e-05	0.000754	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	3.5e-05	0.000743	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—HRAS—colon cancer	3.47e-05	0.000736	CbGpPWpGaD
Vismodegib—SHH—Disease—KRAS—colon cancer	3.44e-05	0.00073	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CASP3—colon cancer	3.34e-05	0.000709	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—HRAS—colon cancer	3.28e-05	0.000698	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCND1—colon cancer	3.25e-05	0.00069	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CTNNB1—colon cancer	3.22e-05	0.000683	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CASP3—colon cancer	3.16e-05	0.000672	CbGpPWpGaD
Vismodegib—SHH—Disease—PIK3CA—colon cancer	3.16e-05	0.000671	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CDKN1A—colon cancer	3.14e-05	0.000668	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCND1—colon cancer	3.08e-05	0.000654	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—AKT1—colon cancer	3.06e-05	0.00065	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CTNNB1—colon cancer	3.05e-05	0.000648	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EP300—colon cancer	2.99e-05	0.000635	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CDKN1A—colon cancer	2.98e-05	0.000633	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.98e-05	0.000632	CbGpPWpGaD
Vismodegib—SHH—Disease—HRAS—colon cancer	2.92e-05	0.000621	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—SRC—colon cancer	2.91e-05	0.000618	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—AKT1—colon cancer	2.9e-05	0.000616	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EP300—colon cancer	2.84e-05	0.000602	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—VEGFA—colon cancer	2.83e-05	0.000602	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NRAS—colon cancer	2.8e-05	0.000594	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.76e-05	0.000587	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—SRC—colon cancer	2.76e-05	0.000586	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.69e-05	0.000571	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—VEGFA—colon cancer	2.69e-05	0.00057	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.66e-05	0.000565	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NRAS—colon cancer	2.65e-05	0.000563	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MYC—colon cancer	2.61e-05	0.000554	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.6e-05	0.000552	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TGFB1—colon cancer	2.6e-05	0.000552	CbGpPWpGaD
Vismodegib—SHH—Disease—AKT1—colon cancer	2.58e-05	0.000548	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EGFR—colon cancer	2.55e-05	0.000541	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	2.47e-05	0.000526	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MYC—colon cancer	2.47e-05	0.000525	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TGFB1—colon cancer	2.46e-05	0.000523	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	2.46e-05	0.000523	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	2.44e-05	0.000519	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EGFR—colon cancer	2.42e-05	0.000513	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—KRAS—colon cancer	2.41e-05	0.000511	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.41e-05	0.000511	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	2.38e-05	0.000506	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ODC1—colon cancer	2.36e-05	0.000501	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CHST5—colon cancer	2.36e-05	0.000501	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.34e-05	0.000498	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—KRAS—colon cancer	2.28e-05	0.000485	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PIK3CA—colon cancer	2.21e-05	0.00047	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	2.18e-05	0.000464	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.16e-05	0.000458	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.15e-05	0.000457	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—colon cancer	2.14e-05	0.000455	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.11e-05	0.000448	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PIK3CA—colon cancer	2.1e-05	0.000445	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HRAS—colon cancer	2.05e-05	0.000435	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—colon cancer	2.03e-05	0.000431	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.99e-05	0.000423	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HRAS—colon cancer	1.94e-05	0.000412	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ABCB1—colon cancer	1.87e-05	0.000397	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	1.86e-05	0.000395	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TYMS—colon cancer	1.84e-05	0.00039	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.83e-05	0.000389	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.81e-05	0.000385	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AKT1—colon cancer	1.81e-05	0.000384	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.8e-05	0.000383	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.77e-05	0.000376	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AKT1—colon cancer	1.71e-05	0.000364	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.62e-05	0.000344	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	1.52e-05	0.000323	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.5e-05	0.000318	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.48e-05	0.000313	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.43e-05	0.000303	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.42e-05	0.000301	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PPARG—colon cancer	1.3e-05	0.000276	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—EP300—colon cancer	1.3e-05	0.000275	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.27e-05	0.00027	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SRC—colon cancer	1.26e-05	0.000268	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—colon cancer	1.23e-05	0.000261	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—NRAS—colon cancer	1.21e-05	0.000257	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.19e-05	0.000252	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.18e-05	0.000251	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.16e-05	0.000247	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCB1—colon cancer	1.16e-05	0.000246	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCB1—colon cancer	1.15e-05	0.000245	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TYMS—colon cancer	1.14e-05	0.000242	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TYMS—colon cancer	1.13e-05	0.000241	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB1—colon cancer	1.13e-05	0.000239	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.06e-05	0.000225	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—KRAS—colon cancer	1.04e-05	0.000222	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCB1—colon cancer	1.04e-05	0.00022	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—colon cancer	1.02e-05	0.000217	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TYMS—colon cancer	1.02e-05	0.000216	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TYMS—colon cancer	9.93e-06	0.000211	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.65e-06	0.000205	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PIK3CA—colon cancer	9.58e-06	0.000204	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCB1—colon cancer	9.45e-06	0.000201	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TYMS—colon cancer	9.28e-06	0.000197	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—colon cancer	9.27e-06	0.000197	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HRAS—colon cancer	8.87e-06	0.000188	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.78e-06	0.000186	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.73e-06	0.000185	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—EP300—colon cancer	8.51e-06	0.000181	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PPARG—colon cancer	8.07e-06	0.000171	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PPARG—colon cancer	8.03e-06	0.000171	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.83e-06	0.000166	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—AKT1—colon cancer	7.83e-06	0.000166	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPARG—colon cancer	7.21e-06	0.000153	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.14e-06	0.000152	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPARG—colon cancer	7.03e-06	0.000149	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPARG—colon cancer	6.57e-06	0.00014	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—colon cancer	6.35e-06	0.000135	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—colon cancer	6.32e-06	0.000134	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CA—colon cancer	6.3e-06	0.000134	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCB1—colon cancer	6.23e-06	0.000132	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TYMS—colon cancer	6.12e-06	0.00013	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—colon cancer	5.67e-06	0.00012	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—colon cancer	5.53e-06	0.000118	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—EP300—colon cancer	5.28e-06	0.000112	CbGpPWpGaD
Vismodegib—ALB—Metabolism—EP300—colon cancer	5.25e-06	0.000112	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—colon cancer	5.17e-06	0.00011	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKT1—colon cancer	5.14e-06	0.000109	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—EP300—colon cancer	4.72e-06	0.0001	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—EP300—colon cancer	4.6e-06	9.77e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPARG—colon cancer	4.33e-06	9.2e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—EP300—colon cancer	4.3e-06	9.13e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CA—colon cancer	3.91e-06	8.3e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CA—colon cancer	3.89e-06	8.25e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CA—colon cancer	3.49e-06	7.41e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—colon cancer	3.41e-06	7.24e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CA—colon cancer	3.4e-06	7.23e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKT1—colon cancer	3.19e-06	6.78e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CA—colon cancer	3.18e-06	6.75e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKT1—colon cancer	3.17e-06	6.74e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKT1—colon cancer	2.85e-06	6.05e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—EP300—colon cancer	2.84e-06	6.02e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKT1—colon cancer	2.78e-06	5.91e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKT1—colon cancer	2.6e-06	5.52e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CA—colon cancer	2.1e-06	4.45e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKT1—colon cancer	1.71e-06	3.64e-05	CbGpPWpGaD
